Projects per year
Personal profile
Education
- 2007 Ph.D., Department of Life Sciences, National Taiwan Normal University
- 1999 Bachelor, Department of Nursing, College of Medicine, National Cheng-Kung University
Experience
- 2023- Professor, Graduate Institute of Pharmacognosy, Taipei Medical University
- 2017-2023 Associate Professor, Graduate Institute of Pharmacognosy, Taipei Medical University
- 2016-2017 Assistant Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2010-2017 Assistant Professor, Graduate Institute of Pharmacognosy, Taipei Medical University
- 2009-2010 Postdoctoral Fellow, Genomics Research Center, Academia Sinica
- 2007-2009 Postdoctoral Fellow, Department of Pharmacology, College of Medicine, National Cheng-Kung University.
Awards
- 2011李鎮源教授醫學研究青年學者獎
Research Interests
- Cancer epigenetic study
- Tumor biology
- Anti-cancer materials
- methods development
Related Link
Fingerprint
Dive into the research topics where Ruo-Kai Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 13 Finished
-
精準血液乳癌檢測試劑組開發(I)
Lin, R.-K. (PI)
11/1/21 → 10/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Prediction System of Cell-Free Methylated Dna Markers for Tracking Treatment Response and Recurrence of Breast Cancer Patients Following Treatment
Lin, R.-K. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Breast Cancer Early Detection and Post-Treatment Smart Healthcare Tracking Platform
Lin, R.-K. (PI)
6/1/19 → 5/1/20
Project: A - Government Institution › b - National Science and Technology Council
-
Study of Novel Genes Regulated by Aberrant Dna Methylation and Application in Colon Cancer Treatment
Lin, R.-K. (PI)
8/1/17 → 7/31/18
Project: A - Government Institution › b - National Science and Technology Council
-
Study of Novel Genes Regulated by Aberrant DNA Methylation and Application in Colon Cancer Treatment
Lin, R.-K. (PI)
8/1/16 → 7/31/17
Project: A - Government Institution › b - National Science and Technology Council
Research output
- 34 Article
-
Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis
Shen, H. T., Hung, C. S., Davis, C., Su, C. M., Liao, L. M., Shih, H. M., Lee, K. D., Ansar, M. & Lin, R. K., May 2024, In: Biomolecules. 14, 5, 571.Research output: Contribution to journal › Article › peer-review
Open Access -
Machine learning approaches for predicting 5-year breast cancer survival: A multicenter study
Nguyen, Q. T. N., Nguyen, P. A., Wang, C. J., Phuc, P. T., Lin, R. K., Hung, C. S., Kuo, N. H., Cheng, Y. W., Lin, S. J., Hsieh, Z. Y., Cheng, C. T., Hsu, M. H. & Hsu, J. C., 2023, (Accepted/In press) In: Cancer Science. 114, 10, p. 4063-4072 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer
Lin, R. K., Su, C. M., Lin, S. Y., Thi Anh Thu, L., Liew, P. L., Chen, J. Y., Tzeng, H. E., Liu, Y. R., Chang, T. H., Lee, C. Y. & Hung, C. S., Dec 2022, In: Molecular Medicine. 28, 1, 67.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus) -
Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
Ansar, M., Thu, L. T. A., Hung, C. S., Su, C. M., Huang, M. H., Liao, L. M., Chung, Y. M. & Lin, R. K., Nov 7 2022, In: Frontiers in Oncology. 12, 1004261.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Automatic detection of the circulating cell-free methylated DNA pattern of GCM2, ITPRIPL1 and CCDC181 for detection of early breast cancer and surgical treatment response
Wang, S. C., Liao, L. M., Ansar, M., Lin, S. Y., Hsu, W. W., Su, C. M., Chung, Y. M., Liu, C. C., Hung, C. S. & Lin, R. K., Mar 2021, In: Cancers. 13, 6, p. 1-26 26 p., 1375.Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Scopus)
Datasets
-
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
Lin, S.-Y. (Creator), Ansar, M. (Creator), Hung, C.-S. (Contributor), Lin, R.-K. (Creator), Chang, S.-C. (Contributor), Chen, J.-Y. (Creator), Jain, S. (Creator), Liew, P.-L. (Contributor) & Wang, S.-C. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.4974518.v1, https://doi.org/10.6084%2Fm9.figshare.c.4974518.v1
Dataset
-
Additional file 1 of Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
Wang, S.-C. (Contributor), Chen, J.-Y. (Creator), Ansar, M. (Creator), Liew, P.-L. (Contributor), Hung, C.-S. (Contributor), Jain, S. (Creator), Chang, S.-C. (Contributor), Lin, R.-K. (Creator) & Lin, S.-Y. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12291872.v1, https://doi.org/10.6084%2Fm9.figshare.12291872.v1
Dataset